Drug Shortage Report for PAMIDRONATE DISODIUM OMEGA 3 MG/ML
Report ID | 2163 |
Drug Identification Number | 02249669 |
Brand name | PAMIDRONATE DISODIUM OMEGA 3 MG/ML |
Common or Proper name | Pamidrontae Disodium for Injection 30mg/10mL |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | DORMANT |
Active Ingredient(s) | PAMIDRONATE DISODIUM |
Strength(s) | 3.0MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10mL vial |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2013-01-01 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2017-10-05 |
Company comments | 6mg/mL and 9mg/mL formats remain available. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2017-03-14 | French | Compare |
v6 | 2017-03-14 | English | Compare |
v5 | 2017-03-14 | French | Compare |
v4 | 2017-03-14 | English | Compare |
v3 | 2017-03-14 | French | Compare |
v2 | 2017-03-14 | English | Compare |
v1 | 2017-03-14 | English | Compare |
Showing 1 to 7 of 7